The Medicare Payment Advisory Commission (MedPAC) released its June 2023 Report to Congress (press release). The report discusses the following topics: High prices of drugs covered under Medicare Part B; Post-sale rebates for prescriptions drugs in Medicare Part D; Standardized benefits in Medicare Advantage (MA) plans; Favorable selection and future directions for MA payment policy; Disparities in outcomes for Medicare beneficiaries with… (Testa, June 15, 2023) #Medicare Advantage, #Medicare Part D, #Mental and Behavioral Health, #Post-Acute Care, #Prescription Drugs, #Telehealth